Catalyst Wire Dossier Catalyst Wire Dossier

INCB013739

· Incyte Corporation
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INCB013739, covering 2012-01-23 to 2018-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics [Phase 2]

See pricing